ConvaTec Group PLC (LSE:CTEC) - Share price - Overview

Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX325.00

Day Change
4.00|1.25%

As of 26/05/2017
17:06:04 BST | GBX
Minimum 15 Minutes Delay.

Last Close321.00p
Day Range320.80 - 325.50
Mkt Cap6.26Bil
52-Wk Range213.00 - 325.50
Yield %0.00
ISINGB00BD3VFW73
Volume8,371,187
P/E-37.69
P/S3.58
P/CF80.63

Share Price

Total Returns 26/05/2017

 Chg (%)  
More ...
ConvaTec Group PLC5.18 
FTSE 100 TR GBP3.92
 
Financials
201420152016
More ...
Income Statement
Turnover1,053.341,080.241,250.69
Operating Profit132.96150.80114.08
Net Profit-77.26-61.13-150.24
Reported EPS-3.95-3.14-10.89
Balance Sheet
Current Assets480.49513.74619.27
Non Current Assets2,041.872,058.622,219.96
Total Assets2,522.352,572.352,843.76
Current Liabilities213.76193.77242.79
Total Liabilities2,664.532,720.801,835.23
Total Equity-142.18-148.451,008.54
Cash Flow
Operating Cash Flow278.73262.07284.84
Net Change in Cash-9.1136.0611.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017370.6316.31-19.68-5.721.78
2018402.4717.597.8218.252.336.572.05

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Sector

Medical Devices

Market Position

80 of 1850 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Outlook

(04/05/2017) "The outlook for the group, and our detailed guidance for the current financial year, are unchanged from that announced at the time of the FY2016 results on 2 March 2017"

Next Event 28/08/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)19.0921.4216.81
Div Yld (E)1.891.554.07
PEG (E)0.022.210.76
ROCE18.5318.7217.40
Op Mrgn9.26-3.71-91.76
EPS Grwth1,285.7824.1827.18
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Christopher Gent
Chief Executive OfficerMr. Paul Moraviec
Chief Financial OfficerNigel Clerkin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.